Matthias Eberl
Impact in
- Immunology top 0.5%
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Parasitology top 2%
- Parasites and Host Interactions
Papers in
- Immunology 58
- T-cell and B-cell Immunology 45
- Immunotherapy and Immune Responses 20
- Immune Response and Inflammation 7
-
- Dialysis and Renal Disease Management 9
- Co-authors
- Hassan Jomaa (18 shared papers)Bernhard Moser (23 shared papers)Martin Hintz (9 shared papers)Jochen Wiesner (6 shared papers)Ewald Beck (10 shared papers)Boran Altincicek (6 shared papers)Ann‐Kristin Kollas (6 shared papers)Silke Sanderbrand (3 shared papers)
- Journals
- The Journal of Immunology (7 papers)Frontiers in Immunology (7 papers)Immunology and Cell Biology (6 papers)European Journal of Immunology (5 papers)FEBS Letters (5 papers)
- Partner nations
- United KingdomGermanyUnited States
In The Last Decade
Matthias Eberl
104 papers receiving 6.3k citations
Matthias Eberl's Hit Papers
Peers
Comparison fields: 5 of 142
- Immunology 2.7k
- Parasitology 373
- Oncology 1k
- Health Informatics 61
- Nephrology 234
Countries citing papers authored by Matthias Eberl
This map shows the geographic impact of Matthias Eberl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Eberl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Eberl more than expected).
Fields of papers citing papers by Matthias Eberl
This network shows the impact of papers produced by Matthias Eberl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Eberl. The network helps show where Matthias Eberl may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthias Eberl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 110 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibitors of the Nonmevalonate Pathway of Isoprenoid Biosynthesis as Antimalarial Drugs Hit paper breakdown → | 1999 | 1003 |
| 2 | 2007 | 431 | |
| 3 | 2001 | 316 | |
| 4 | 2003 | 271 | |
| 5 | 2010 | 268 | |
| 6 | 2009 | 233 | |
| 7 | 2007 | 123 | |
| 8 | 2015 | 121 | |
| 9 | 2009 | 112 | |
| 10 | 2011 | 112 | |
| 11 | 2001 | 106 | |
| 12 | 2019 | 105 | |
| 13 | 2002 | 103 | |
| 14 | 2014 | 96 | |
| 15 | 2011 | 95 | |
| 16 | 2001 | 93 | |
| 17 | 2018 | 93 | |
| 18 | 2011 | 88 | |
| 19 | 2001 | 86 | |
| 20 | 2010 | 83 |
About Matthias Eberl
Matthias Eberl is a scholar working on Immunology, Nephrology, Parasitology, Oncology and Information Systems and Management, having authored 110 papers that have together received 6.5k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (45 papers), Immunotherapy and Immune Responses (20 papers), Plant biochemistry and biosynthesis (10 papers), Dialysis and Renal Disease Management (9 papers), Immune Response and Inflammation (7 papers), Parasites and Host Interactions (6 papers), Sepsis Diagnosis and Treatment (4 papers) and Academic Publishing and Open Access (4 papers). The work is most often cited by research in Immunology (2.7k citations), Parasitology (373 citations), Oncology (1k citations), Health Informatics (61 citations) and Nephrology (234 citations). Matthias Eberl has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include Hassan Jomaa, Bernhard Moser, Martin Hintz, Jochen Wiesner, Ewald Beck, Boran Altincicek, Ann‐Kristin Kollas, Silke Sanderbrand, Armin Reichenberg and Hartmut K. Lichtenthaler. Their work appears in journals such as The Journal of Immunology, Frontiers in Immunology, Immunology and Cell Biology, European Journal of Immunology and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.